|
Volumn 92, Issue 1, 2001, Pages 126-135
|
Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy
|
Author keywords
fetoprotein; Cirrhosis; Hepatocellular carcinoma; Percutaneous ethanol injection; Survival analysis; Tumor recurrence
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALCOHOL;
ALPHA FETOPROTEIN;
ASPARTATE AMINOTRANSFERASE;
ADULT;
AGED;
ARTICLE;
CANCER RECURRENCE;
CANCER SURVIVAL;
DISEASE ASSOCIATION;
FEMALE;
FOLLOW UP;
HUMAN;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
MAJOR CLINICAL STUDY;
MALE;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
SURVIVAL RATE;
THROMBOCYTE COUNT;
ADMINISTRATION, CUTANEOUS;
ADULT;
AGED;
AGED, 80 AND OVER;
ALPHA-FETOPROTEINS;
CARCINOMA, HEPATOCELLULAR;
ETHANOL;
FEMALE;
HUMANS;
LIVER CIRRHOSIS;
LIVER NEOPLASMS;
MALE;
MIDDLE AGED;
PLATELET COUNT;
PROGNOSIS;
RECURRENCE;
SURVIVAL ANALYSIS;
SURVIVAL RATE;
TRANSAMINASES;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 0035397554
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/1097-0142(20010701)92:1<126::AID-CNCR1300>3.0.CO;2-V Document Type: Article |
Times cited : (76)
|
References (47)
|